Speaker Profile
M.D., Ph.D., Professor of Neurology, Emory U.
Biography
Dr. Levey is the Robert W. Woodruff Professor of Neurology and founding director of the Goizueta Brain Health Institute and Goizueta Alzheimer’s Disease Research Center at Emory University. Dr. Levey is the Robert W. Woodruff Professor of Neurology and founding director of the Goizueta Brain Health Institute and Goizueta Alzheimer’s Disease Research Center at Emory University. He has led several NIH translational research consortia focused on precision medicine for Alzheimer’s disease and related neurodegenerative disorders, including programs in the Accelerating Medicine Partnership for AD and one of two national Drug Discovery Centers for AD (TREAT-AD), contributing to pioneering proteomics research that has discovered novel therapeutic targets and biomarkers, now in clinical translation. He is recipient of numerous awards including from the American Neurological Association, Alzheimer’s Association, National Parkinson’s Foundation, Huntington’s Disease Society of America, and he is an elected member of the National Academy of Medicine and the Association of American Physicians.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
David Liebeskind, UCLA
PMWC Award Ceremony
• Li-Huei Tsai, MIT Picower Institute (Pioneer)
• Thomas C. Südhof, Stanford (Nobel Laureate, Pioneer)
• David Holtzman, WashU (Pioneer)
• Henrik Zetterberg, UCL / Gothenburg (Luminary)
Featured Speakers
• Thomas C. Südhof, Stanford
• Li-Huei Tsai, MIT Picower Institute
• David Holtzman, WashU
• Henrik Zetterberg, UCL / Gothenburg
• Mark Mintun, Lilly
• Randall Bateman, WashU
• Nikolaos Mellios, Circular Genomics
• Robert Rissman, USC
• Lynn Kramer, Eisai
• Thomas F. Tropea, University of Pennsylvania
• Ari J. Green, UCSF
• Diane Chan, Mass General Brigham
• Leslie Shaw, University of Pennsylvania
• Prashanthi Vemuri, Mayo Clinic
• Kejal Kantarci, Mayo Clinic
• Dan Huddleston, Lightbox Science
• Patrick Brannelly, 10K Brains
• Allan Levey, Emory
From Blood Test to Treatment
Are we finally diagnosing Alzheimer's early enough to change care?
Precision Diagnostics Across Neurology
From biomarker to bedside across neurological disease.
Neurodegeneration Beyond Alzheimer's
Parkinson's, ALS, and FTD in the precision era.
AI & Imaging Across Neurological Disease
Precision phenotyping in stroke, epilepsy, and neurodegeneration.
Why Precision Neurology Is Not Scaling
The evidence, infrastructure, access, and workflow barriers that must be fixed.
Harnessing Brain Rhythms
Gamma oscillations, brain circuits, and the future of neurotherapy.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
